Estrogen Signaling in Lung Cancer: An Opportunity for Novel Therapy
AbstractLung cancer is the leading cause of cancer death in U.S. and represents a major public health burden. Epidemiologic data have suggested that lung cancer in women may possess different biological characteristics compared to men, as evidenced by a higher proportion of never-smokers among women with lung cancer. Emerging data indicate that female hormones such as estrogen and progesterone play a significant role in lung carcinogenesis. It has been reported that estrogen and progesterone receptors are expressed in lung cancer cell lines as well as in patient-derived tumors. Hormone related risk factors such as hormone replacement therapy have been implicated in lung carcinogenesis and several preclinical studies show activity of anti-estrogen therapy in lung cancer. In this review, we summarize the emerging evidence for the role of reproductive hormones in lung cancer and implications for lung cancer therapy. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Baik, C.S.; Eaton, K.D. Estrogen Signaling in Lung Cancer: An Opportunity for Novel Therapy. Cancers 2012, 4, 969-988.
Baik CS, Eaton KD. Estrogen Signaling in Lung Cancer: An Opportunity for Novel Therapy. Cancers. 2012; 4(4):969-988.Chicago/Turabian Style
Baik, Christina S.; Eaton, Keith D. 2012. "Estrogen Signaling in Lung Cancer: An Opportunity for Novel Therapy." Cancers 4, no. 4: 969-988.